Mihael H. Polymeropoulos

2017

In 2017, Mihael H. Polymeropoulos earned a total compensation of $3.8M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 47% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$502,200
Option Awards$1,456,406
Salary$675,000
Stock Awards$1,131,000
Other$32,789
Total$3,797,395

Polymeropoulos received $1.5M in option awards, accounting for 38% of the total pay in 2017.

Polymeropoulos also received $502.2K in non-equity incentive plan, $675K in salary, $1.1M in stock awards and $32.8K in other compensation.

Rankings

In 2017, Mihael H. Polymeropoulos' compensation ranked 2,740th out of 14,666 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 81.3% of executives.

ClassificationRankingPercentile
All
2,740
out of 14,666
81st
Division
Manufacturing
947
out of 5,772
84th
Major group
Chemicals And Allied Products
250
out of 2,075
88th
Industry group
Drugs
190
out of 1,731
89th
Industry
Pharmaceutical Preparations
152
out of 1,333
89th
Source: SEC filing on April 27, 2018.

Polymeropoulos' colleagues

We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2017.

2017

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

2017

Gian Reverberi

Vanda Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2017

Gunther Birznieks

Vanda Pharmaceuticals

Senior Vice President, Business Development

2017

Richard Gulino

Vanda Pharmaceuticals

General Counsel

News

You may also like